A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

NCT00525499 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2011-11-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

Conditions

  • Acne Vulgaris

Interventions

DRUG

ASC-J9 cream

Topical application to the face twice daily for 12 weeks.

DRUG

placebo

vehicle control applied topically twice daily for 12 weeks

Sponsors & Collaborators

  • AndroScience Corp

    lead INDUSTRY

Principal Investigators

  • Charles CY Shih, PhD · AndroScience Corp

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-04-30
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00525499 on ClinicalTrials.gov